Summary

The global atherectomy and thrombectomy devices market is projected to be valued at US$ 4.2 Bn in 2025 and is anticipated to reach US$ 6.4 Bn by 2032, growing at a CAGR of 6.20% between 2025 and 2032. These devices play a critical role in minimally invasive vascular procedures for removing plaque and blood clots, improving blood flow, and reducing the risk of severe cardiovascular complications. The market is expanding rapidly due to rising incidences of peripheral artery disease (PAD) and deep vein thrombosis (DVT), coupled with growing preference for catheter-based interventions over open surgeries. Advancements in imaging and catheter design have further boosted adoption rates in hospitals and specialty clinics.

Atherectomy and Thrombectomy Devices Market – Report Scope:

The market covers a broad portfolio of devices, including rheolytic, aspiration, rotational, and ultrasound-based systems, designed to address various vascular blockages. Their use spans across hospitals, clinics, and other healthcare settings to treat arterial and venous diseases effectively. Growing awareness about early intervention, an aging global population, and rising healthcare expenditure are key factors fueling market penetration. Continuous innovation—such as drug-coated devices, image-guided navigation, and compact designs—is enhancing procedural success rates and expanding treatment options for physicians.

Market Growth Drivers:

The market is driven by increasing prevalence of cardiovascular and vascular diseases, including PAD, coronary artery disease, and ischemic stroke, which demand efficient plaque and clot removal solutions. Technological advancements in device design, integration of real-time imaging, and improved safety features are boosting procedural outcomes and adoption. An expanding elderly population, favorable reimbursement frameworks in developed countries, and growing investments in vascular care infrastructure further support market growth.

Market Restraints:

High device costs and procedure-related expenses remain significant barriers, especially in developing economies. Potential risks, such as vessel wall injury or distal embolization, may limit patient acceptance. Stringent regulatory approval processes and lengthy clinical trials delay product launches. Additionally, a shortage of skilled interventional specialists in some regions poses challenges for wider adoption of these advanced treatment modalities.

Market Opportunities:

Development of next-generation atherectomy and thrombectomy devices with enhanced safety, precision, and clot capture capabilities presents significant opportunities. Expanding into emerging markets with growing healthcare infrastructure can unlock new revenue streams. Collaborations between device manufacturers and research institutions could accelerate innovations such as AI-assisted navigation and predictive treatment planning, improving procedural outcomes and opening new commercial possibilities.

Regional Outlook:

North America will remain the leading market, supported by advanced healthcare facilities, high procedure volumes, and strong presence of global medical device manufacturers. The U.S. dominates with robust adoption of minimally invasive vascular treatments and favorable reimbursement structures. Europe follows, with Germany, France, and the U.K. investing heavily in endovascular care. The Asia Pacific region is set to witness the fastest growth due to increasing prevalence of vascular diseases, rising healthcare spending, and rapid adoption of advanced medical technologies in China, India, and Japan. Latin America and the Middle East & Africa are gradually growing markets, driven by improving access to care and growing medical tourism.

Leading Companies:

Key players in the global atherectomy and thrombectomy devices market include Medtronic, Boston Scientific, Spectranetics, Bayer AG, Cardiovascular Systems, Argon Medical Devices, Getinge AB, Straub Medical AG, Teleflex, Terumo Medical, and Abbott. These companies focus on product innovation, expanding their device portfolios, and forging partnerships with healthcare providers to strengthen market presence.

Companies Covered in This Report:

• Medtronic

• Boston Scientific

• Spectranetics

• Bayer AG

• Cardiovascular Systems

• Argon Medical Devices

• Getinge AB

• Straub Medical AG

• Teleflex

• Terumo Medical

• Abbott

Market Segmentation:

By Type:

• Rheolytic

• Aspiration

• Rotational

• Ultrasound Device

By Application:

• Hospitals

• Clinics

• Others

By Region:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Atherectomy and Thrombectomy Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
3.1. Global Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Rheolytic
3.1.1.2. Aspiration
3.1.1.3. Rotational
3.1.1.4. Ultrasound Device
3.2. Global Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Clinics
3.2.1.3. Others
3.3. Global Atherectomy and Thrombectomy Devices Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
4.1. North America Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Rheolytic
4.1.1.2. Aspiration
4.1.1.3. Rotational
4.1.1.4. Ultrasound Device
4.2. North America Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Clinics
4.2.1.3. Others
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. U.S. Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
4.3.1.2. U.S. Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
4.3.1.3. Canada Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
4.3.1.4. Canada Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
5.1. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Rheolytic
5.1.1.2. Aspiration
5.1.1.3. Rotational
5.1.1.4. Ultrasound Device
5.2. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Clinics
5.2.1.3. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Germany Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.2. Germany Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.3. U.K. Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.4. U.K. Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.5. France Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.6. France Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.7. Italy Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.8. Italy Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.9. Turkey Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.10. Turkey Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.11. Russia Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.12. Russia Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.1.13. Rest of Europe Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.3.1.14. Rest of Europe Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
6.1. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Rheolytic
6.1.1.2. Aspiration
6.1.1.3. Rotational
6.1.1.4. Ultrasound Device
6.2. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Clinics
6.2.1.3. Others
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. China Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.2. China Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.1.3. Japan Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.4. Japan Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.1.5. South Korea Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.6. South Korea Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.1.7. India Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.8. India Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.1.9. Southeast Asia Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.10. Southeast Asia Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.1.11. Rest of Asia Pacific Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.3.1.12. Rest of Asia Pacific Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
7.1. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Rheolytic
7.1.1.2. Aspiration
7.1.1.3. Rotational
7.1.1.4. Ultrasound Device
7.2. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1.1. Hospitals
7.2.1.2. Clinics
7.2.1.3. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Brazil Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.3.1.2. Brazil Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
7.3.1.3. Mexico Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.3.1.4. Mexico Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
7.3.1.5. Argentina Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.3.1.6. Argentina Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
7.3.1.7. Rest of Latin America Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.3.1.8. Rest of Latin America Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, 2019-2032
8.1. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Rheolytic
8.1.1.2. Aspiration
8.1.1.3. Rotational
8.1.1.4. Ultrasound Device
8.2. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Clinics
8.2.1.3. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. GCC Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.3.1.2. GCC Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
8.3.1.3. South Africa Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.3.1.4. South Africa Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
8.3.1.5. Egypt Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.3.1.6. Egypt Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
8.3.1.7. Nigeria Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.3.1.8. Nigeria Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
8.3.1.9. Rest of Middle East & Africa Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.3.1.10. Rest of Middle East & Africa Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2019-2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Application Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Boston Scientific
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Spectranetics
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Bayer AG
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Cardiovascular Systems
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Argon Medical Devices
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Getinge AB
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Straub Medical AG
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Teleflex
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Terumo Medical
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Abbott
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations